Mitchell Arnold - 19 Feb 2025 Form 4 Insider Report for Petros Pharmaceuticals, Inc. (PTPI)

Role: Vice Pres. of Finance & Chief Acc. Off.
Signature: /s/ Mitchell Arnold
Issuer symbol: PTPI
Transactions as of: 19 Feb 2025
Net transactions value: $0
Form type: 4
Filing time: 21 Feb 2025, 17:34:57 UTC
Previous filing: 26 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTPI	Common Stock	Award	$0	+150,000		$0.000000	150,000	19 Feb 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date.

Content

Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date.

Remarks:

Vice Pres. of Finance & Chief Acc. Off.